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Skin is one of the major tissues displaying chronic
diabetic complications. We have studied glucose
transport following stimulation with insulin and IGF-
1 in cultured mouse keratinocytes. In proliferating
cells, acute stimulation with insulin and IGF-1
increased glucose uptake. Insulin translocated glu-
cose transporters 1 and 5, whereas IGF-1 translocated
glucose transporters 2 and 3. With differentiation,
glucose transporter 3 expression increased and the
expression of glucose transporters 1, 2, and 5
decreased. No increase in glucose uptake was
observed, however, following stimulation with either
hormone. These results indicate that insulin and
IGF-1 differentially regulate glucose uptake as well as
expression and translocation of speci®c transporters
in skin keratinocytes. Key words: glucose transport/glu-
cose transporters/growth factors/insulin/keratinocytes/skin.
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S
kin is one of the major tissues that display pathologic
changes associated with diabetes mellitus (Jelinek, 1993;
Sibbald et al, 1996). These include dermatologic disorders
associated with diabetes such as impaired wound healing,
diabetes dermopathy, and other conditions such as
necrobiosis lipoidica diabeticorum, waxy skin, and acanthosis
nigricans (Huntley, 1993). Although numerous studies on experi-
mental diabetic models have revealed abnormal glucose transport in
classical insulin-responsive tissues such as muscle, fat, and liver,
detailed studies on other tissues such as skin have not been reported.
Insulin and IGF-1 have each been shown to be important for
skin function (Benoliel et al, 1997; Smola et al, 1998). Both
hormones promote proliferation and migration of human and
mouse keratinocytes. In addition, insulin is an essential component
in the growth medium of human keratinocytes in vitro (Tsao et al,
1982). Furthermore, a defect in skin development was observed in
IGF receptor (IGFR) null mice (Liu et al, 1993). As skin is not
considered to be a major insulin-responsive tissue, however, little is
known about the effects of the insulin family of proteins on
regulation of metabolic processes in skin keratinocytes. As is well
known, insulin and IGF-1 control glucose transport in numerous
tissues. Indeed, defects in glucose transport have been shown to
contribute to the development of diabetic complications in various
tissues (Huntley, 1993; Jelinek, 1993; Smola et al, 1998). The fact
that skin dermatologic complications occur in diabetes would
appear to indicate that defects in insulin signaling or regulation of
glucose metabolism may be involved. Nonetheless, effects of
insulin and IGF-1 on glucose transport in skin and its association
with growth and differentiation have not been reported.
The transport of glucose across the cell plasma membrane occurs
by facilitative diffusion mediated by a family of transmembrane
glycoproteins termed glucose transporters (GLUTs) (Gould and
Holman, 1993; Olson and Pessin, 1996). It is currently believed
that GLUTs have some degree of tissue speci®city. GLUT 1 is
known to be ubiquitously expressed (Wertheimer et al, 1991),
whereas GLUT 2 is mostly expressed in liver, kidney, intestine, and
pancreatic b-cells, GLUT 3 is mostly expressed in muscle, heart,
and adipocytes, and GLUT 4 is mostly expressed in cardiac muscles,
skeleton muscles, and fat cells. GLUT 5 has been identi®ed in small
intestine, brain, muscle, and adipose tissue (Takata, 1996). A
number of tissues express more than one glucose transporter:
skeletal muscle expresses GLUTs 1, 3, and 4, adipose tissue
expresses GLUTs 1 and 4, and heart expresses GLUTs 3 and 4
(Gould and Holman, 1993; Pascoe et al, 1996). Stimulation of
glucose uptake, especially by insulin given acutely, occurs via
translocation of the GLUTs from the cytoplasm to the plasma
membrane (Klip et al, 1993; Cushman et al, 1998). Studies on
human keratinocytes have shown that these cells seem to express
only GLUT 1 (Gherzi et al, 1992; Voldstedlund and Dabelsteen,
1997). A detailed analysis of GLUT expression in the various stages
of skin differentiation has not been reported, however.
Furthermore, although it was found that insulin and IGF-1
increase glucose uptake and GLUT 1 expression (Gherzi et al,
1992), detailed studies on GLUT translocation were not done.
The purpose of this study was to characterize the glucose
transport system in skin keratinocytes and to examine the effects of
insulin and IGF-1 on glucose transport in these cells. In order to do
so, we utilized a culture system of mouse keratinocytes. The
differentiation state of these cells can be regulated by adjusting the
extracellular calcium concentrations (Hennings et al, 1980).
Primary mouse keratinocytes cultured in vitro in medium contain-
ing a low concentration of Ca2+ (0.05 mM) retain a proliferative
basal cell phenotype with a high growth rate. Elevation of calcium
concentrations above 0.1 mM Ca2+ induces a rapid sequence of
events leading to loss of proliferation potential and to differentiation
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of keratinocytes. Further elevation of the Ca2+ concentration to
1.0 mM is associated with terminal differentiation, formation of
corni®ed envelopes, and cell death. Differentiated cells ultimately
slough from the culture dish as mature squames. This program of
calcium-induced differentiation in vitro closely follows the matura-
tion pattern of epidermis in vivo (Yuspa et al, 1989).
This study characterizes the glucose transport system in
keratinocytes including the expression of several GLUTs.
Moreover, we show that insulin and IGF-1 speci®cally increase
glucose transport in skin keratinocytes, and induce distinct changes
in expression and translocation of different GLUTs. Preliminary
results have been reported.1
MATERIALS AND METHODS
Materials Tissue culture media and serum were purchased from
Biological Industries (Beit HaEmek, Israel). Enhanced chemical
luminescence was performed with a kit purchased from BioRad (Israel).
Polyclonal antibodies to GLUTs 1, 2, 3, and 5 were a gift from Dr. S.
Cushman (Diabetes Branch, NIDDK, NIH); horseradish peroxidase
antirabbit and antimouse IgG were obtained from Bio-Rad. Leupeptin,
aprotinin, phenylmethylsulfonyl ¯uoride (PMSF), dithiothreitol,
orthovanadate, and pepstatin were purchased from Sigma (St. Louis,
MO). Insulin (HumulinR-recombinant human insulin) was purchased
from Lilly France SA (Fergersheim, France). IGF-1 was a gift from Cytolab
(Israel).
Isolation and culture of murine keratinocytes Primary keratinocytes
were isolated as described previously (Dlugosz et al, 1995) from newborn
BALB/C mice. Keratinocytes were cultured in Eagle's minimal essential
medium containing fetal bovine serum treated with 8% Chelex (Chelex-
100, BioRad). To maintain a proliferative basal cell phenotype, the ®nal
Ca2+ concentration was adjusted to 0.05 mM. Experiments were performed
5±7 d after plating.
Preparation of cell extracts and western blot analysis For crude
membrane fractions, lysates were prepared by scraping cells with a rubber
policeman into phosphate-buffered saline (PBS) containing 10 mg per ml
aprotinin, 10 mg per ml leupeptin, 2 mg per ml pepstatin, 1 mM PMSF,
10 mM ethylenediamine tetraacetic acid, 200 mM NaVO4, and 10 mM
NaF. After four cycles of freeze-thaw, cells were homogenized and
centrifuged at 4°C for 20 min at 2300 3 g. The supernatant containing the
soluble protein fraction (cytoplasmic extract) was transferred to another
tube. This fraction contained both the cytoplasmic proteins and internal
membranes where GLUTs are localized prior to translocation. The pellet
was resuspended in 250 ml PBS containing 1% Triton X-100 with protease
and phosphatase inhibitors. Cells were incubated for 30 min at 4°C and
centrifuged at 2300 3 g at 4°C. The supernatant containing the membrane
fraction was transferred to a fresh tube. The cytoplasmic and membrane
extracts were frozen at ±70°C until used. The purity of the membrane
preparations was con®rmed by the expression of speci®c membrane
markers (Na/K pump a1 isoform). The purity of the cytoplasmic extract
was con®rmed by expression of MAPK and p-MAPK, which in our model
system of keratinocyte expression is localized in the cytoplasmic extract.
The remaining pellet contained cytoskeletal proteins. Protein
concentrations were measured using a modi®ed Lowry assay (Bio-Rad
DC Protein Assay Kit). According to the protein levels it was routinely
con®rmed that the relative protein ratio between membrane and
cytoplasmic extracts was maintained at 1:7. Western blot analysis of
cellular protein fractions was carried out as described previously
(Tennenbaum et al, 1996).
Glucose transport Glucose transport was evaluated by measuring 2-
deoxy-[3H]-glucose according to the method described previously
(Wertheimer et al, 1990). Brie¯y, on the day of the experiment, cells
were washed three times with PBS. Then, 0.1 mM 2-deoxy-glucose/PBS
with tracer amounts of 2-deoxy-[3H]-glucose (1 mCi per plate; ARC, St.
Louis, MO) was added to the cells. Uptake was continued for 10 min at
37°C. The reaction was stopped by three quick washes with 1.0 ml cold
PBS on ice, and cells were lyzed in 1% Triton X-100. The samples were
counted in the [3H] window of a Tricarb scintillation counter. Uptake was
linear under these conditions for up to 15 min (Fig 1). Mean values were
determined from measurements of triplicate samples under each
experimental condition for each experiment.
RESULTS
Basal glucose transport We ®rst examined basal glucose uptake
in proliferating and differentiating keratinocytes. As mentioned,
keratinocytes maintained in a low Ca2+ concentration (0.05 mM)
express properties of basal proliferating cells. Elevating the Ca2+
concentration to above 0.1 mM induces rapid differentiation; cells
express speci®c differentiation markers and cease to proliferate. We
measured basal glucose uptake of cells maintained in different
concentrations at various time points, and the results are illustrated
in Fig 1. It can be seen that in both proliferating and differentiating
keratinocytes a linear basal uptake was observed in the range of 0±
40 min uptake. Maximal glucose uptake was observed in
keratinocytes cultured in low Ca2+ concentrations. These cells
present basal-like keratinocytes that are highly proliferative and
metabolically active.
As GLUTs mediate the transport of glucose into cells, we next
identi®ed the GLUTs expressed in keratinocytes. As seen in Fig 2,
keratinocytes at all Ca2+ concentrations express GLUTs 1, 2, 3, and
5, but there were changes in GLUT expression as a function of
Ca2+ concentration. Thus, Ca2+-induced differentiation was
associated with increased expression of GLUT 3 and decreased
expression of GLUTs 1, 2, and 5.
Effects of insulin and IGF-1 on glucose uptake One of the
major functions of insulin is to promote the transport of glucose
into cells. As we have found that several GLUTs are expressed in
keratinocytes maintained in different Ca2+ concentrations, we
investigated the effects of insulin and IGF-1 on glucose uptake in
these cells. The results are summarized in Fig 3. In proliferating
keratinocytes maintained in 0.05 mM Ca2+, insulin treatment for
1 h and 24 h increased glucose uptake by 60% and 120%,
respectively. In contrast, stimulation with IGF-1 increased
glucose uptake by 150% as early as 5 min after addition of the
hormone, and by nearly 300% after 15 min (Fig 3A). Similar to
stimulation with insulin, glucose uptake by IGF-1 remained
elevated (120% above control) for up to 24 h. Thus, the effect of
IGF-1 on glucose uptake occurred sooner and was stronger than
that of insulin. Surprisingly, although differentiating keratinocytes
express several GLUTs, elevation of extracellular Ca2+ was
Figure 1. Basal glucose uptake in proliferating and differentiating
keratinocytes. Primary keratinocytes were isolated and plated as described
in Materials and Methods. Proliferating keratinocytes were maintained for 5 d
in low Ca2+ medium (0.05 mM) until they reached 80% con¯uency.
Differentiation was then induced by elevating the Ca2+ concentration in
the growth medium from 0.05 mM (d) to 0.12 mM (m) and 1.0 mM (j).
Cells were allowed to differentiate for 24 h. Glucose uptake was carried out
as described in Materials and Methods for the times indicated. Each symbol
represents the mean 6 SE of three determinations in ®ve experiments done
on separate cultures.
1Shen S, Wertheimer E, Bak A, Tennenbaum T, Sampson SR:
Proceedings of the International Symposium on Insulin Receptor and
Insulin Action, p. 211, 1998 (abstr.)
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associated with abolition of the response to both insulin and IGF-1
(Fig 3B). As neither insulin nor IGF-1 had a detectable effect on
glucose uptake in differentiating keratinocytes, all subsequent
studies were done on basal proliferating keratinocytes.
Effects of insulin and IGF-1 on GLUTs
Acute effects The ®nding that insulin and IGF-1 increase glucose
uptake in proliferating basal keratinocytes suggests that these
hormones might differentially activate various GLUTs in these
cells. Accordingly, we determined which transporters are affected
by insulin and IGF-1. The results are shown in Fig 4. As activation
of GLUTs is usually associated with translocation of the transporters
to the plasma membrane, we initially followed the distribution of
GLUTs following acute stimulation with insulin and IGF-1 in
keratinocytes. As a plasma membrane marker we used the Na/K
pump a1 isoform. As expected (Fig 4A), expression of the Na/K
pump a1 isoform was limited to the plasma membrane fraction. It
can be seen that insulin translocated both GLUTs 1 and 5 from the
cytoplasm to the plasma membrane within 5 min (Fig 4A, C), and
this effect was maintained for at least 60 min. Insulin had no effect
on any of the other isoforms within this time period. In contrast,
IGF-1 translocated both GLUT 2 and GLUT 3 from the cytoplasm
to the plasma membrane within 5 min, and these transporters
remained elevated in the plasma membrane for at least 60 min.
IGF-1 had no effect on any of the other isoforms within this time
period (Fig 4B, C). At the same time, administration of insulin or
IGF-1 for 60 min did not affect the total expression of the various
GLUTs (Fig 4D). Thus insulin and IGF-1 each translocated
distinct, separate GLUT isoforms to produce its effects on glucose
transport.
Chronic effects One possible explanation for the increased glucose
transport with chronic treatment is a change in expression and
distribution of the individual transporters from that in nonstimu-
lated cells. To identify which of the GLUTs were affected by
chronic insulin or IGF-1 stimulation, we performed western blot
analysis of cytoplasmic and plasma membrane extracts from lysates
of cells treated with insulin and IGF-1 for 24 h. The results are
shown in Fig 5(A). Following 24 h treatment with insulin, the
expression of GLUTs 2 and 3, which were not translocated by
acute insulin stimulation, was found to be upregulated in both
cytoplasmic and plasma membrane extracts. GLUTs 1 and 5, which
were translocated by insulin acutely, remained elevated in the
plasma membrane for 24 h. In contrast, IGF-1 treatment for 24 h
resulted in increased levels of GLUTs 1 and 5 in both cytoplasmic
and plasma membrane extracts; these transporters were not affected
by IGF-1 given acutely. GLUTs 2 and 3, which were translocated
by IGF-1 given acutely, remained elevated in the plasma membrane
for 24 h. The increase in total expression of the transporters was also
veri®ed by results obtained from total lysates. In Fig 5(B) it can be
seen that the total expression of GLUTs 2 and 3 was increased by
insulin, whereas expression of GLUTs 1 and 5 was increased by
IGF-1. Thus, chronic treatment with either insulin or IGF-1
resulted in retention of acutely translocated GLUTs in the plasma
membrane with an additional increase in membrane expression of
all transporters.
DISCUSSION
Glucose represents a major fuel for most mammalian cells, and a
wide range of factors regulate its utilization. Indeed, impaired
Figure 2. Expression of GLUTs in proliferating and differentiating
keratinocytes. Cells were cultivated as described in Fig 1. Total cell
lysates (20 mg protein) were analyzed by western blotting using speci®c
polyclonal antibodies to each transporter. Brain extract was used as positive
control for GLUTs 1 and 3. Kidney extract was used as positive control for
GLUT 2 and muscle was used as positive control for GLUT 5. The blots
shown are representative of three different experiments.
Figure 3. Effects of insulin or IGF-1 on glucose uptake by
keratinocytes maintained in different Ca2+ concentrations. 2-
deoxy-[3H]-glucose uptake was measured as described in Materials and
Methods. Each bar represents the mean 6 SE of three determinations in ®ve
experiments done on separate cultures. Values are expressed as a percentage
of control, unstimulated cells from the same culture in each experiment.
The control level of unstimulated cells was 30 mmol 2-deoxy-[3H]-glucose
per mg protein per min. (A) Five-day-old keratinocytes were maintained in
0.05 mM Ca2+ and stimulated with 10±7 M insulin (open bars) or 10±8 M
IGF-1 (®lled bars) for the designated times. (B) Keratinocytes were induced
to differentiate by elevation of [Ca2+] from 0.05 mM (open bars) to 0.12 mM
(slashed bars) and to 1.0 mM (®lled bars) for 24 h. Cells in all Ca2+
concentrations were treated for 60 min with insulin (10±7 M) or IGF-1
(10±8 M).
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regulation of glucose transport and metabolism, as seen in diabetes,
leads to the development of chronic complications. All tissues
utilize glucose and have basal glucose transport mechanisms.
Insulin-responsive tissues, such as skeletal muscle and fat, respond
to acute insulin stimulation by further increasing the rate of glucose
transport. Skin is not considered to be an insulin-responsive tissue,
however, and its glucose transport system has not been thoroughly
characterized. In this study, we have shown that proliferating skin
keratinocytes indeed possess an intact glucose transport system and
express four GLUT isoforms ± GLUTs 1, 2, 3, and 5. In earlier
studies (Gherzi et al, 1992; Voldstedlund and Dabelsteen, 1997), it
was reported that cultured human keratinocytes apparently express
GLUT 1. Similarly, GLUT 1 was identi®ed in intact skin by
immunostaining techniques (Voldstedlund and Dabelsteen, 1997).
Figure 4. Acute effects of insulin and IGF-1 on the distribution of GLUTs in proliferating keratinocytes. Five-day-old keratinocytes were
maintained in 0.05 mM Ca2+ and stimulated with 10±7 M insulin (A) or 10±8 M IGF-1 (B) for the designated times. Cells were cultivated as described in
Fig 1. Following stimulation with insulin or IGF-1 for the designated times, cytoplasmic (cyto) and plasma membrane (mem) extracts were prepared
according to Materials and Methods. Twenty micrograms protein were analyzed by western blotting using speci®c polyclonal antibodies to each transporter.
The quality of the fractionation procedure was con®rmed by following the expression of the Na/K pump a1 isoform, a plasma membrane protein. (C)
Densitometry analyses of membrane (open bars) and cytoplasmic (®lled bars) extracts from a representative western blot obtained in one of three separate
experiments on the effects of insulin (INS) and IGF-1 (IGF) at the 60 min time period are calculated as a percentage of values obtained from control
unstimulated cells. (D) Total expression of GLUTs in whole cell lysates was analyzed in keratinocytes stimulated for 60 min by insulin and IGF-1. Twenty
micrograms protein were analyzed by western blotting using speci®c polyclonal antibodies to each transporter.
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In these studies, however, the expression of other GLUTs was not
examined. Reports on a variety of tissues have shown that many
cells concurrently express several GLUT isoforms. For example,
GLUTs 1, 2, and 5 have been identi®ed in other epithelial cell
types, including human eye retina, corneal cells, and absorptive cells
in the small intestine (Kumagai et al, 1994; Watanabe et al, 1994;
Takahashi et al, 1996; Takata, 1996; Voldstedlund and Dabelsteen,
1997).
Interestingly, we have found that the rate of glucose transport as
well as the expression levels of certain GLUTs change as a function
of differentiation. Proliferating keratinocytes had the highest
glucose transport rate. This was associated with a high expression
level of GLUTs 1, 2, and 5. As proliferating keratinocytes have a
high metabolic rate compared with the other differentiating or
terminally differentiated keratinocytes, association of high glucose
transport and high levels of GLUT expression with this state is
obvious. As expected, induction of differentiation was associated
with a downregulation in transport rate. Whereas induction of
differentiation was associated with a decrease in expression of
GLUTs 1, 2, and 5, however, GLUT 3 expression increased.
Similar to our ®ndings, it has been shown that expression of GLUT
3 is associated with differentiation in other tissues as well. For
example, a lack of GLUT 3 was associated with abnormal muscle
differentiation (Broydell et al, 1997; Mazzuca and Lo, 1998).
Another possible explanation for the differential regulation of the
various GLUT isoforms is that they may be involved in different
cellular functions. Support of this notion is provided by studies
showing speci®c intracellular localization of certain GLUT isoforms
in epithelial cells. For example, in polar epithelial cells (kidney or
intestine) GLUTs 1 and 2 have been shown to be expressed on the
basolateral membrane, whereas GLUTs 3 and 5 are expressed on
the apical membrane (Harris et al, 1992; Miller et al, 1992; Pascoe
et al, 1996).
GLUT isoform expression was also found to be differentially
regulated by hormonal stimulation. We have shown that insulin
and IGF-1 stimulate glucose uptake in proliferating keratinocytes,
the latter growth factor having a stronger effect than the former.
Whereas insulin acutely translocated GLUTs 1 and 5, however, this
change was not associated with a change in glucose transport.
Moreover, although translocation from the cytoplasmic to the
membrane fraction of GLUT 1 by insulin and GLUT 2 by IGF-1
was complete, only partial translocation of GLUT 5 by insulin and
GLUT 3 by IGF-1 was evident. On calculating the total expression
levels of the proteins in both fractions, cytoplasmic expression levels
were still higher than the total expression levels in the membrane
fraction. In contrast, chronic insulin as well as both acute and
chronic IGF-1 treatment led to an increased expression of GLUTs
2 and 3 in the plasma membrane and this increase was associated
with elevated glucose transport. These results show a discrepancy
between GLUT translocation and glucose transport. Furthermore,
there was an association between membrane expression of GLUTs
2 and 3 and changes in glucose transport. GLUT 1 and 5
translocation did not result in increased 2-deoxy-[3H]-glucose
uptake, however. Indeed it has recently been suggested that glucose
transport requires not only GLUT translocation but GLUT
activation as well (Sweeney et al, 1999). It is possible that acute
insulin stimulation of proliferating keratinocytes, although leading
to translocation of GLUTs, did not result in their activation.
Finally, we have found that the effects of insulin and IGF-1 were
exerted exclusively on proliferating cells. There is some uncer-
tainty, however, as to whether insulin effects are exerted via
activation of insulin receptor (IR) or by activation of IGFR. Based
on reports of small amounts of IR in primary cultures of human
keratinocytes (Verrando and Ortonne, 1985), it was proposed that
both growth factors exert their effects primarily on the IGFR
(Gherzi et al, 1992). Although Gherzi et al's ®ndings were
quantitatively consistent with this hypothesis, our ®ndings of
differential effects of insulin and IGF-1, both acutely and
chronically, on GLUT translocation suggest that each growth
factor acts primarily via its own receptor and signaling pathway.
Moreover, functional IR and IGFR have both been shown to be
expressed in primary keratinocytes (Wertheimer et al, 2000). Their
activity is decreased during induction of keratinocyte differentia-
tion, however (Wertheimer et al, 2000). Furthermore, in several
cell models including cardiac myocytes and adipocytes, insulin-
induced glucose uptake was found to be also mediated by the
GLUT 1 transporter in addition to GLUT 4. Thus, the actual
decrease in expression levels of the various GLUTs during
keratinocyte differentiation could explain the lack of responsiveness
to insulin stimulation (Calderhead et al, 1990; Robinson and James,
1992; Fischer et al, 1997; Egert et al, 1999). Altogether, these results
might explain the lack of response of the glucose transport system
Figure 5. Chronic effects of insulin and IGF-1 on GLUT expression
in proliferating keratinocytes. Western blots showing chronic effects of
insulin (INS) or IGF-1 (IGF) on GLUT expression and distribution in
primary keratinocytes. Cells were cultivated as described in Fig 1.
Keratinocytes were stimulated with 10±7 M insulin or 10±8 M IGF-1 for
24 h. (A) Cytoplasmic (cyto) and plasma membrane (mem) extracts were
prepared according to Materials and Methods. Twenty mg protein were
analyzed by western blotting using speci®c polyclonal antibodies to each
transporter. (B) Twenty micrograms of protein of total cell lysates were
analyzed for GLUT expression by western blotting using speci®c polyclonal
antibodies to each transporter.
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to insulin and IGF-1 stimulation in differentiating cells.
Nonetheless, insulin and IGF-1 may exert other as yet undescribed
metabolic effects on differentiating keratinocytes. Studies are
currently being undertaken to clarify the major signaling mechan-
isms in insulin- and IGF-1 induced effects in skin cells.
In summary, our results demonstrate that skin keratinocytes
possess a hormone-sensitive glucose transport system that is
regulated during differentiation. Furthermore, we have shown that
insulin and IGF-1 differentially regulate the glucose transport
system. Further studies are required to identify the speci®c role of
insulin, IGF-1, and the glucose transport system in normal as well as
pathologic skin physiology.
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